Market Share. The HSCRC and the Hospital will monitor the Hospital’s market share on an ongoing basis by analyzing and identifying changes in the levels of the Hospital’s patient volumes that are derived from its Primary Service Area (PSA) or Secondary Service Area (SSA) as defined in Appendix E. The HSCRC staff and the Hospital will also monitor the total level of services and revenues which are provided by the Hospital to Maryland residents who live outside of the Primary and Secondary service areas of the Hospital, or to patients who live outside of Maryland in other states or foreign countries, and will track (to the extent possible) any changes in in-migration and out-migration patterns and their effects on the Hospital. The HSCRC will make appropriate adjustments in the Hospital’s Approved Regulated Revenue based on significant changes in the Hospital’s market share or service levels; provided, however, that the HSCRC does not intend to provide increases in the Approved Regulated Revenue of individual hospitals based on market share analysis for volume increases that are not offset by reductions in the Approved Regulated Revenue(s) of other hospitals. The HSCRC also does not intend to make revenue adjustments based on market share changes that would discourage the Hospital from reducing its level of Potentially Avoidable Utilization.
Market Share. The percentage of Members enrolled with a particular PH-MCO when compared to the total of Members enrolled in all the PH-MCOs within a HealthChoices Zone. Master Provider Index — A component of the Department’s MMIS which is a central repository of Provider profiles and demographic information that registers and identifies Providers uniquely within the Department of Human Services.
Market Share. The percentage of Members enrolled with a particular PH-MCO when compared to the total of Members enrolled in all the PH-MCOs within a HealthChoices Zone. Medicaid Eligibility Determination Automation (MEDA) — Part of the Client Information System (CIS) that automates the determination of Medicaid eligibility. Medical Assistance (MA) — The Medical Assistance Program authorized by Title XIX of the federal Social Security Act, 42 U.S.C. 1396 et seq., and regulations promulgated thereunder, and 62 P.S. §441.1 et seq. and regulations at 55 PA Code Chapters 1101 et seq.
Market Share. The Declaration applies on condition that the market share held by the supplier does not exceed 30% of the relevant market on which it sells the contract goods or services and the market share held by the buyer does not exceed 30% of the relevant market on which it purchases the contract goods or services.
Market Share. The percentage of Members enrolled with a particular PH-MCO when compared to the total of Members enrolled in all the PH-MCOs within a HealthChoices Zone.
Market Share. The Primary Dealer shall make every reasonable effort to maintain in the Client Market, for each calendar quarter, market shares of not less than 2.5 per cent of the total turnover on this market.
Market Share. Market share shall be determined by reference to the percentage difference between: (i) the total number of Company units shipped during the fiscal year ending immediately prior to the Performance Period divided by the number of Housing and Urban Development Code Home shipments during the same period and (ii) the total number of Company units shipped during the last fiscal year of the Performance Period divided by the number of Housing and Urban Development Code Home shipments during the same period. For this purpose, all shipments shall include acquisitions and all units shipped, whether HUD code homes or other. Relative Total Shareholder Return (“rTSR”): rTSR shall be determined with respect to the Company and the rTSR Comparator Companies by dividing: (a) the sum of (i) the difference between the applicable Beginning Stock Price and the applicable Ending Stock Price plus (ii) all dividends and other distributions on the respective shares with an ex-dividend date that falls during the Performance Period by (b) the applicable Beginning Stock Price. To determine the Company’s applicable percentile ranking, the Company and each rTSR Comparator Company are arranged by their respective total shareholder returns (highest to lowest). For this purpose:
Market Share. As an adjunct to Sections 1-8 and including any additional assumptions, demonstrate the impact on market share as a result of the PLA Submission. Projected Market in Alberta as a Result of the PLA Terms (% Market Share) • List projected market shares as total number of patients and percentage of total market for each disease state/indication resulting from the PLA Submission. • Market shares for years one, two and three must be reported for a full calendar year. • State where the proposed market is coming from (e.g., new patients, cannibalization of another product’s market share). Incremental Change in Market in Alberta as a Result of the PLA Submission (% Market Share) • Indicate the net change in market share from the original BIA as a result of the PLA Submission. • As an adjunct to Sections 1-9 and including any additional assumptions, demonstrate the impact on pharmacy program costs as a result of the PLA Submission. Direct drug costs to the Alberta Health and Wellness sponsored drug programs as a Result of the PLA Terms • Calculate the direct prescription costs that the Government-Sponsored Drug Plans would incur as a result of the PLA Submission. • Prescription costs should be an extension of the prevalence of the disease state/indication, the projected market share of the product and the prescription costs to the Government-Sponsored Drug Plans as calculated in Section 3. Incremental Direct drug to the Alberta Health and Wellness sponsored drug programs as a Result of the PLA Terms • Calculate the incremental change in direct prescription costs from outlined in Sections 1-9 that the Alberta Health and Wellness sponsored drug benefit programs would incur as a result of the PLA offer • Calculate relevant one-way and/or multi-way sensitivity analyses for direct prescription costs and incremental prescription cost changes outlined in Sections 1-9 as a result of the PLA offer.
Market Share. Agreement-Wide Trade (or Sub-Trade): U.S. Inbound (or Outbound) Name Time Period: [Calendar Quarter] Agreement Market Share: Percent Line A [Name] ................................................................................................................................................. X,XXX XX Line B ............................................................................................................................................................... X,XXX XX Line C ............................................................................................................................................................... X,XXX XX Etc. . . .
